Description
The rise of super-potent synthetic opioids, including isotonitazene and brorphine, has intensified the public health burden of opioid toxicity and overdose. While naloxone remains the primary reversal agent for opioid-induced respiratory depression, limited data exist regarding its effectiveness against emerging synthetic opioid analogues with high μ-opioid receptor affinity and super-agonist properties.
This study investigates the cytotoxic and inflammatory effects of isotonitazene and brorphine in vitro using RAW264.7 macrophage and BV2 microglial cell models. Lactate dehydrogenase (LDH) assays were used to assess cytotoxicity, and ELISA quantification of pro-inflammatory cytokines, TNF-α was performed to evaluate immune response modulation. Additionally, we examined the temporal and dose-dependent effects of naloxone co-administration to better characterize its antagonistic potential against these synthetic opioids.
Our findings aim to contribute to a mechanistic drug profile of emerging synthetic opioids and inform future translational strategies for overdose prevention, naloxone dosing optimization, and public health response efforts.
Disciplines
Cell Biology | Laboratory and Basic Science Research | Other Pharmacology, Toxicology and Environmental Health | Pharmacology | Toxicology
Keywords
Isotonitazene, Brorphine, Naloxone, Synthetic Opioids, Neuroinflammation, Cytotoxicity, Public Health
Document Type
Poster
Recommended Citation
Mkhize, Ayanda C.; Lopez, Kalissa; Stewart, Madison; Joseph, Henrichka; and Jimenez, Victor M., "Investigating the Antagonist Properties of Naloxone in Synthetic Isotonitazene and Brorphine in Brain Microglial Cells" (2026). Annual Research Symposium. 9.
https://ecommons.roseman.edu/researchsymposium/2026/basic_sciences/9
Investigating the Antagonist Properties of Naloxone in Synthetic Isotonitazene and Brorphine in Brain Microglial Cells
The rise of super-potent synthetic opioids, including isotonitazene and brorphine, has intensified the public health burden of opioid toxicity and overdose. While naloxone remains the primary reversal agent for opioid-induced respiratory depression, limited data exist regarding its effectiveness against emerging synthetic opioid analogues with high μ-opioid receptor affinity and super-agonist properties.
This study investigates the cytotoxic and inflammatory effects of isotonitazene and brorphine in vitro using RAW264.7 macrophage and BV2 microglial cell models. Lactate dehydrogenase (LDH) assays were used to assess cytotoxicity, and ELISA quantification of pro-inflammatory cytokines, TNF-α was performed to evaluate immune response modulation. Additionally, we examined the temporal and dose-dependent effects of naloxone co-administration to better characterize its antagonistic potential against these synthetic opioids.
Our findings aim to contribute to a mechanistic drug profile of emerging synthetic opioids and inform future translational strategies for overdose prevention, naloxone dosing optimization, and public health response efforts.